
Erlotiva 100 Tablet
Marketer
GLS Pharma Ltd.
Salt Composition
Erlotinib (100mg)
Overview Erlotiva 100 Tablet
Erlotiva 100mg tablets treat non-small cell lung and pancreatic cancers. Administer this medication on an empty stomach, or at least one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Strictly adhere to prescribed dosage; incorrect usage or overdose can cause severe adverse effects. Benefits may take weeks or months to appear; do not discontinue without your doctor's instruction. Common side effects include nausea, vomiting, tiredness, skin rashes, and weight loss. Severe diarrhea requires increased fluid intake or medical attention. Photosensitivity is possible; wear protective clothing and sunscreen outdoors. Report mouth sores, vision changes, or breathing problems immediately. Regular liver function tests may be recommended. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners. Smoking cessation is advised as it can impair treatment efficacy. If using antacids or other medications, maintain a minimum two-hour interval between doses.
Primary Ingredients of Erlotiva 100 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Erlotiva 100 Tablet
Cancers of the pancreas and non-small-cell lung
Major Benefits of Erlotiva 100 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Erlotiva 100 Tablet on an empty stomach.
Common Side effects of Erlotiva 100 Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Erlotiva 100 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Erlotiva 100 Tablet on an empty stomach.
How Erlotiva 100 Tablet works:
Erlotiva 100 Tablet combats lung cancer. Its mechanism involves targeting epidermal growth factor receptors (EGFR), which regulate the growth of lung cancer cells. By attaching to EGFR, the drug blocks the cancer's signaling pathways, effectively halting its proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erlotiva 100 Tablet has unknown safety implications. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Erlotiva 100 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in extremely rare, life-threatening circumstances where the potential benefits clearly outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Erlotiva 100 Tablet. Scant evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Erlotiva 100 Tablet is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Erlotiva 100 Tablet is suitable for patients with kidney disease, requiring no dosage modification. However, its use is contraindicated in individuals with severely impaired kidney function.
LiverCAUTION
Patients with liver impairment should use Erlotiva 100mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Erlotiva 100 Tablet :
Omit any missed Erlotiva 100 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Erlotiva 100 Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
